Cre-loxP as an option in cardiovascular disease research

The Cre-LoxP system is based on site-specific recombination mediated by the enzyme Cre recombinase. This system allows spatiotemporal control of gene expression in inducible models by utilizing specific promoters or enhancers that direct the expression of Cre recombinase in particular tissues or as a response to external signals at a specific moment in the life of the model organism, such as drug administration. In cardiovascular research, the Cre-LoxP system has been fundamental in generating mouse models replicating specific human pathological conditions. A growing area of interest is the use of Cre-LoxP in optogenetics, where it allows the expression of light-sensitive ion channels to modulate the activity of specific tissues such as the heart. This approach provides new avenues for studying cardiac electrophysiology and developing targeted therapeutic strategies.